Feed Preview

Fast Growing

Microbiome and MS

Microbiome and MS diagram by Soleil Nordic, Shutterstock
Soleil Nordic, Shutterstock

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research on the influence of the human microbiome on this dymyelinating disorder.

Top 20 most recent papers
Lancet Neurology

The gut microbiome in neurological disorders

Lancet NeurologyNovember 23, 2019
John F CryanTimothy G Dinan
506
3
9
131
Neurology. Neuroimmunology and Neuroinflammation

Normal gut microbiome in NMDA receptor encephalitis

Neurology. Neuroimmunology and NeuroinflammationOctober 19, 2019
Julia HerkenHarald Prüss
24
2
10
Frontiers in Microbiology

Skin Exposure to Narrow Band Ultraviolet (UVB) Light Modulates the Human Intestinal Microbiome

Frontiers in MicrobiologyNovember 12, 2019
Else S BosmanBruce A Vallance
254
35
9
42
Nature Reviews. Neurology

Microbiome varies between multiple sclerosis subtypes

Nature Reviews. NeurologyApril 4, 2020
Ian Fyfe
Autoimmunity Reviews

Multiple sclerosis, the microbiome, TLR2, and the hygiene hypothesis

Autoimmunity ReviewsNovember 18, 2019
Nicholas J WaskoRobert B Clark
11
2
Nutrients

Nutrition, IBD and Gut Microbiota: A Review

NutrientsApril 3, 2020
Mentella Maria ChiaraMiggiano Giacinto Abele Donato
1
Journal of Neuroinflammation

Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review

Journal of NeuroinflammationNovember 23, 2019
Mohammad MorshediElaheh-Sadat Hosseinifard
3
Clinical and Experimental Gastroenterology

Inflammation in gastrointestinal disorders: prevalent socioeconomic factors

Clinical and Experimental GastroenterologyAugust 15, 2019
Davide Giuseppe RibaldoneGiovanni Clemente Actis
15
1
10
Frontiers in Immunology

Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis

Frontiers in ImmunologyMarch 6, 2020
Lorenzo GaetaniTeresa Zelante
2
Microbiology and Molecular Biology Reviews : MMBR

Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer

Microbiology and Molecular Biology Reviews : MMBRMarch 6, 2020
Matteo BelloneSamuel Huber
4
Methods in Molecular Biology

Microbiome as an Immunological Modifier

Methods in Molecular BiologySeptember 11, 2019
Manoj KumarSouhaila Al Khodor
5
2
13
Multiple Sclerosis and Related Disorders

The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review

Multiple Sclerosis and Related DisordersNovember 11, 2019
Wolfgang MarxRELIEF Trial team
17
13
Multiple Sclerosis and Related Disorders

The multiple sclerosis gut microbiota: A systematic review

Multiple Sclerosis and Related DisordersMarch 17, 2020
Ali MirzaHelen Tremlett
2
8
Autoimmunity Reviews

The gut microbiota perspective for interventions in MS

Autoimmunity ReviewsJune 10, 2019
Magdalena Zoledziewska
12
27
OncoTargets and Therapy

Novel cancer therapy targeting microbiome

OncoTargets and TherapyJune 14, 2019
Tatsuya NaganoYoshihiro Nishimura
5
33

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/microbiome-and-ms/300264ee-2362-4185-98b9-a2ca266c176a